$5.57
00.00%
Pre-Market: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
LifeStance Health Gr
LFSTNASDAQ
LifeStance Health Gr (NASDAQ:LFST) Stock, Analyst Ratings, Price Targets, Forecasts
LifeStance Health Group Inc has a consensus price target of $9 based on the ratings of 8 analysts. The high is $10 issued by Morgan Stanley on April 22, 2024. The low is $8 issued by Barclays on February 29, 2024. The 3 most-recent analyst ratings were released by Morgan Stanley, Jefferies, and Goldman Sachs on April 22, 2024, March 6, 2024, and March 4, 2024, respectively. With an average price target of $9.33 between Morgan Stanley, Jefferies, and Goldman Sachs, there's an implied 67.56% upside for LifeStance Health Group Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Morgan Stanley
Jefferies
Goldman Sachs
Barclays
JP Morgan
1calculated from analyst ratings
Analyst Ratings for LifeStance Health Gr
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/22/2024 | Buy Now | 79.53% | Morgan Stanley | Ricky Goldwasser | $10 → $10 | Reiterates | Overweight → Overweight | Get Alert |
| 03/06/2024 | Buy Now | 61.58% | Jefferies | Brian Tanquilut | $8 → $9 | Maintains | Buy | Get Alert |
| 03/04/2024 | Buy Now | 61.58% | Goldman Sachs | Jamie Perse | $8 → $9 | Maintains | Neutral | Get Alert |
| 02/29/2024 | Buy Now | 43.63% | Barclays | — | $7 → $8 | Maintains | Underweight | Get Alert |
| 11/22/2023 | Buy Now | 43.63% | Goldman Sachs | Jamie Perse | $9 → $8 | Maintains | Neutral | Get Alert |
| 11/17/2023 | Buy Now | 43.63% | JP Morgan | Lisa Gill | $10 → $8 | Maintains | Neutral | Get Alert |
| 08/10/2023 | Buy Now | 79.53% | JP Morgan | Lisa Gill | $9 → $10 | Maintains | Neutral | Get Alert |
| 07/13/2023 | Buy Now | 79.53% | Morgan Stanley | Ricky Goldwasser | $10 → $10 | Reiterates | Overweight → Overweight | Get Alert |
| 05/19/2023 | Buy Now | 61.58% | Goldman Sachs | Jamie Perse | $8 → $9 | Maintains | Neutral | Get Alert |
| 05/11/2023 | Buy Now | 79.53% | Morgan Stanley | Ricky Goldwasser | $8 → $10 | Maintains | Overweight | Get Alert |
| 01/06/2023 | Buy Now | 43.63% | Morgan Stanley | Ricky Goldwasser | → $8 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 11/15/2022 | Buy Now | 43.63% | Goldman Sachs | Jamie Perse | $9 → $8 | Maintains | Neutral | Get Alert |
| 11/14/2022 | Buy Now | 43.63% | Cowen & Co. | Gary Taylor | $10 → $8 | Maintains | Outperform | Get Alert |
| 11/07/2022 | Buy Now | — | Jefferies | Brian Tanquilut | — | Assumes | → Buy | Get Alert |
| 08/22/2022 | Buy Now | 79.53% | Cowen & Co. | Gary Taylor | $11 → $10 | Maintains | Outperform | Get Alert |
| 05/10/2022 | Buy Now | 43.63% | Morgan Stanley | Ricky Goldwasser | $10 → $8 | Maintains | Equal-Weight | Get Alert |
| 03/21/2022 | Buy Now | 79.53% | Goldman Sachs | Jamie Perse | $15 → $10 | Maintains | Neutral | Get Alert |
| 03/17/2022 | Buy Now | 79.53% | UBS | Kevin Caliendo | $19 → $10 | Downgrade | Buy → Neutral | Get Alert |
| 12/17/2021 | Buy Now | 79.53% | Morgan Stanley | — | — | Maintains | Equal-Weight | Get Alert |
| 11/09/2021 | Buy Now | 115.44% | JP Morgan | Lisa Gill | — | Downgrade | Overweight → Neutral | Get Alert |
| 09/10/2021 | Buy Now | 223.16% | Cowen & Co. | Gary Taylor | — | Initiates | → Outperform | Get Alert |
| 08/16/2021 | Buy Now | 187.25% | Morgan Stanley | Ricky Goldwasser | — | Downgrade | Overweight → Equal-Weight | Get Alert |
FAQ
What is the target price for LifeStance Health Gr (LFST) stock?
The latest price target for LifeStance Health Gr (NASDAQ:LFST) was reported by Morgan Stanley on April 22, 2024. The analyst firm set a price target for $10.00 expecting LFST to rise to within 12 months (a possible 79.53% upside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for LifeStance Health Gr (LFST)?
The latest analyst rating for LifeStance Health Gr (NASDAQ:LFST) was provided by Morgan Stanley, and LifeStance Health Gr reiterated their overweight rating.
When was the last upgrade for LifeStance Health Gr (LFST)?
The last upgrade for LifeStance Health Group Inc happened on January 6, 2023 when Morgan Stanley raised their price target to $8. Morgan Stanley previously had an equal-weight for LifeStance Health Group Inc.
When was the last downgrade for LifeStance Health Gr (LFST)?
The last downgrade for LifeStance Health Group Inc happened on March 17, 2022 when UBS changed their price target from $19 to $10 for LifeStance Health Group Inc.
When is the next analyst rating going to be posted or updated for LifeStance Health Gr (LFST)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of LifeStance Health Gr, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for LifeStance Health Gr was filed on April 22, 2024 so you should expect the next rating to be made available sometime around April 22, 2025.
Is the Analyst Rating LifeStance Health Gr (LFST) correct?
While ratings are subjective and will change, the latest LifeStance Health Gr (LFST) rating was a reiterated with a price target of $10.00 to $10.00. The current price LifeStance Health Gr (LFST) is trading at is $5.57, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.